Načítá se...
Treatment strategies for DNA repair-deficient prostate cancer
INTRODUCTION: Common recurrent genetic alterations have been identified in prostate cancer through comprehensive sequencing efforts, and the prevalence of mutations in DNA repair pathway genes in patients with advanced and metastatic disease approaches 20–25%. Identification of these underlying DNA...
Uloženo v:
| Vydáno v: | Expert Rev Clin Pharmacol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6088808/ https://ncbi.nlm.nih.gov/pubmed/28573914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1338138 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|